ALK inhibitors for non-small cell lung cancer: A systematic review and network meta-analysis.

<h4>Background</h4>We sought to assess the relative effects of individual anaplastic lymphoma kinase (ALK) inhibitors for the treatment of non-small cell lung cancer (NSCLC).<h4>Methods</h4>We searched MEDLINE, Embase, Cochrane CENTRAL, and grey literature (July 23, 2019) for...

Full description

Saved in:
Bibliographic Details
Main Authors: Jesse Elliott, Zemin Bai, Shu-Ching Hsieh, Shannon E Kelly, Li Chen, Becky Skidmore, Said Yousef, Carine Zheng, David J Stewart, George A Wells
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2020-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0229179&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!